Chirgwin, J., Sun, Z., Smith, I., Price, K. N., Thürlimann, B., Ejlertsen, B., . . . Coates, A. S. (2011). The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause. Breast Cancer Res Treat.
シカゴスタイル引用形Chirgwin, Jacquie, et al. "The Advantage of Letrozole Over Tamoxifen in the BIG 1-98 Trial Is Consistent in Younger Postmenopausal Women and in Those With Chemotherapy-induced Menopause." Breast Cancer Res Treat 2011.
MLA引用形式Chirgwin, Jacquie, et al. "The Advantage of Letrozole Over Tamoxifen in the BIG 1-98 Trial Is Consistent in Younger Postmenopausal Women and in Those With Chemotherapy-induced Menopause." Breast Cancer Res Treat 2011.